<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from (a) Gelman
Sciences Inc. Statement of Income and Consolidated Statement of Cash Flows
for the nine months ended April 30, 1996 an the Consolidated Balance Sheet as
of April 30, 1996 and is qualified in its entirety by reference to such (b)
Form 10-Q for the third quarter ended April 30, 1996.
</LEGEND>
<CIK> 0000310252
<NAME> GELMAN SCIENCES INC.
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS
       
                               
<PERIOD-TYPE>                      9-MOS
<FISCAL-YEAR-END>                  JUL-31-1996
<PERIOD-END>                       APR-30-1996
<EXCHANGE-RATE>                                    1
<CASH>                                         7,010
<SECURITIES>                                       0
<RECEIVABLES>                                 27,864
<ALLOWANCES>                                   1,388
<INVENTORY>                                   13,408
<CURRENT-ASSETS>                              51,791
<PP&E>                                        73,535
<DEPRECIATION>                                39,952
<TOTAL-ASSETS>                                87,955
<CURRENT-LIABILITIES>                         14,238
<BONDS>                                        7,532
<COMMON>                                         794
<PREFERRED-MANDATORY>                              0
<PREFERRED>                                        0
<OTHER-SE>                                    65,391
<TOTAL-LIABILITY-AND-EQUITY>                  87,955
<SALES>                                       83,961
<TOTAL-REVENUES>                              83,961
<CGS>                                         40,957
<TOTAL-COSTS>                                 40,957
<OTHER-EXPENSES>                              33,361
<LOSS-PROVISION>                                 164
<INTEREST-EXPENSE>                               447
<INCOME-PRETAX>                                9,032
<INCOME-TAX>                                   2,621
<INCOME-CONTINUING>                            6,411
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                                   6,411
<EPS-PRIMARY>                                   0.78
<EPS-DILUTED>                                   0.78